Efficacy of Risankizumab on Symptoms in Patients With Scalp Psoriasis in a Post-Hoc Analysis of the UnlIMMited Phase 4 Randomized Clinical Trial at Week 16. (2025). SKIN The Journal of Cutaneous Medicine, 9(6), s636. https://doi.org/10.25251/57ey8s02